Related Experiment Video
Updated: Mar 21, 2026

Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine
Published on: October 11, 2019
Historical Review: Problematic Malaria Prophylaxis with Quinine.
1Australian Army Malaria Institute, Enoggera, Australia. School of Population Health, University of Queensland, Brisbane, Australia. Department of Zoology, University of Oxford, Oxford, United Kingdom. dennis.shanks@defence.gov.au.
Quinine was the first malaria chemoprophylaxis drug but had compliance issues and public health drawbacks. Its limitations highlight the need for better preventive medications.
Area of Science:
- Pharmacology
- Tropical Medicine
- Public Health
Background:
- Quinine, derived from cinchona bark, was historically the primary drug for malaria chemoprophylaxis.
- Its use dates back to the 19th century, facing challenges in consistent administration and efficacy verification.
Observation:
- Compliance with quinine prophylaxis was difficult, even in structured settings like the military.
- Concerns existed regarding its overall prophylactic effectiveness and potential for rare severe adverse events like blackwater fever.
Findings:
- Quinine prophylaxis could be counterproductive, leading to suppressed infections that still produced gametocytes, thus sustaining mosquito infectivity.
- A global pharmaceutical cartel controlled quinine supply, creating a monopoly and impacting availability, particularly during geopolitical events like WWII.
Implications:
- The challenges associated with quinine underscore the inherent difficulties in developing and implementing preventive medications.
- There is a clear and ongoing need for the development of improved chemoprophylactic compounds for infectious diseases like malaria.
Related Concept Videos
Anthelminthic Agents
Inhibitors of Bacterial DNA Synthesis
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Cholinergic Antagonists: Pharmacokinetics

